Neuroplast receives second orphan medicinal product designat

Fast-track status is granted for frontotemporal dementia, next to the existing designation for traumatic spinal cord injury An orphan medicinal product designation or orphan disease designation

Related Keywords

Geleen , Limburg , Netherlands , Amsterdam , Noord Holland , Dutch , Kostenloser Wertpapierhandel , Erik Wolters , Brightlands Agrifood Fund , Committee For Orphan Medicinal Products , European Union , Netherlands Enterprise Agency , European Medicines Agency , Dutch Ministry Of Economic Affairs , Frontotemporal Dementia , Traumatic Spinal Cord Injury , Traumatic Brain , Advanced Therapy Medicinal Product , Orphan Medicinal Products , Johannes De Munter , Lumana Invest , Brightlands Venture Partners , Netherlands Enterprise , Brightlands Chemelot Campus , Venture Partners , Chemelot Ventures , Dutch Ministry , Economic Affairs , Spring Lifesciences Communication , Neuroplast , Eceives , Second , Orphan , Medicinal , Product , Resignation , Euro , Cells , Caving , Application , Moth , Hronic , Trauma , Induced , Neurodegenerative , Diseases ,